SEPTANEST N 0.005 MG
EPINEPHRINE (EPINEPHRINE BITARTRATE) : 0.005 MG ARTICAINE HYDROCHLORIDE : 40 MG · DIN 02123371 · SEPTODONT
Health Canada status: MARKETED
What is SEPTANEST N?
SEPTANEST N 0.005 MG contains EPINEPHRINE (EPINEPHRINE BITARTRATE) : 0.005 MG ARTICAINE HYDROCHLORIDE : 40 MG. It is listed in the Health Canada Drug Product Database under DIN 02123371, held by SEPTODONT, supplied as SOLUTION for BLOCK/INFILTRATION administration. Health Canada currently lists it as marketed, status dated 31-Dec-1994. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SEPTANEST N used for?
Infiltration anesthesia and nerve block anesthesia in clinical dentistry, including extractions, oral surgery, and muco-gingival operations.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02123371 |
|---|---|
| Brand name | SEPTANEST N |
| Generic / active ingredient | EPINEPHRINE (EPINEPHRINE BITARTRATE) : 0.005 MG ARTICAINE HYDROCHLORIDE : 40 MG |
| Manufacturer | SEPTODONT |
| Strength | 0.005 MG |
| Dosage form | SOLUTION |
| Route of administration | BLOCK/INFILTRATION |
| Schedule | Ethical |
| ATC code | N01BB58 ARTICAINE, COMBINATIONS |
| AHFS class | 72:00.00 ; 52:32.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-Dec-1994 |
| Original market date | 1994-12-31 00:00:00 |
How is it administered?
Infiltration or nerve block. Adults: 1.7 mL usually sufficient; max 7 mg/kg. Children (4+): dose based on age/weight; max 7 mg/kg. Administer slowly (1 mL/min) with frequent aspiration.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in provided text (standard practice is 15-30°C, but text only mentions disinfection of cartridges).
How is it supplied?
1.7 mL glass cartridges, box of 50 cartridges.
Contraindications
Known allergies to articaine or ingredients (including sulphites); asthma with sulfite sensitivity; intravascular injection; uncontrolled epilepsy.
Warnings and precautions
Risk of toxic reactions (convulsions, respiratory arrest) from overdose/accidental IV injection. Contains epinephrine (cardiovascular caution). Risk of methemoglobinemia.
What can be used instead?
Other Canadian products sharing ATC code N01BB58 ARTICAINE, COMBINATIONS. 12 of 18 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| 4% ASTRACAINE DENTAL WITH EPINEPHRINE 1:200,000 (0.005MG/ML) | 0.005 MG | SOLUTION | DENTSPLY CANADA LIMITED | MARKETED | DIN 02248489 |
| 4% ASTRACAINE DENTAL WITH EPINEPHRINE FORTE 1:100,000 (0.01MG/ML) | 40 MG | SOLUTION | DENTSPLY CANADA LIMITED | MARKETED | DIN 02248488 |
| ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION | 0.009 MG | SOLUTION | PIERREL S.P.A. | MARKETED | DIN 02339536 |
| ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION | 0.018 MG | SOLUTION | PIERREL S.P.A. | MARKETED | DIN 02339544 |
| ORABLOC 1:100,000 | 0.018 MG | SOLUTION | PIERREL S.P.A. | MARKETED | DIN 02361914 |
| ORABLOC 1:200,000 | 40 MG | SOLUTION | PIERREL S.P.A. | MARKETED | DIN 02361906 |
| POSICAINE N | 40 MG | SOLUTION | NOVOCOL PHARMACEUTICAL OF CANADA INC | MARKETED | DIN 02381311 |
| POSICAINE SP | 40 MG | SOLUTION | NOVOCOL PHARMACEUTICAL OF CANADA INC | MARKETED | DIN 02381338 |
| SEPTANEST SP | 0.01 MG | SOLUTION | SEPTODONT | MARKETED | DIN 02123398 |
| ULTRACAINE D-S FORTE INJECTION | 40 MG | SOLUTION | HANSAMED LIMITED | MARKETED | DIN 01988557 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.